Tel: +44 (0)1223 316 855
life science research products, biological research products, biotechnology
close ...


Supplier:
Product types:
Extensive Portfolio Of Ion Channel Cell Lines
Ion Channel Screening & Profiling Services
Comprehensive Epigenetic Profiling and Screening Services

Calcium, Voltage-Gated Channels

Cambridge Bioscience, through our collaboration with B’SYS, offers access to screening services for the following voltage-gated calcium channel targets:
Cav1.2/β2/α2δ1
Gene Name: CACNA1C/CACNB2/CACNA2D1
Description: The human CACNA1C gene encodes the pore-forming subunits of Cav1.2. CACNB2 and CACNA2D1 encode auxiliary subunits that modulate gating and pharmacological properties. Cav1.2 channels are expressed in heart, smooth muscle, neurons and endocrine tissue and are therapeutic targets in cardiac arrhythmia and hypertension.

Cav2.1/β3/α2δ2
Gene Name: CACNA1A/CACNB3/CACNA2D2 or CACNA2D4
Description: The human CACNA1A gene encodes the pore-forming subunit of Cav2.1, the voltage-gated P/Q-type calcium channel. CACNB3 and CACNA2D2 or D4 encode auxiliary subunits that modulate gating and pharmacological characteristics. Mutations in CACNA1A are responsible for several inherited neurologic disorders including familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6 epilepsy. Cav2.1 channels expressed in neurons are therapeutic targets in pain management.

Cav3.1
Gene Name: CACNA1G
Description: The human CACNA1G gene encodes the pore-forming subunit of Cav3.1, a voltage-gated T-type calcium channel. Cav3.1 channels are expressed in neuronal cell membranes and may have roles in epilepsy, pain sensing and cardiac pacemaking.

Cav3.2
Gene Name: CACNA1H
Description: The human CACNA1H gene encodes the pore-forming subunit of Cav3.2, a voltage-gated T-type calcium channel. Mutations in CACNA1H have been linked to inherited neurologic diseases including idiopathic, generalised and childhood absence epilepsies. Cav3.2 channels expressed in CNS neurons and non-neuronal tissues (sinoatrial node, atrioventricular node, kidney, liver, and vascular endothelium) are therapeutic targets in seizures, hypertension, angina, neuropathic pain, insomnia, and cancer.

Speak to a Specialist
To discuss a calcium channel screening project with one of our specialists, please Click Here
Contact Our B'SYS Specialist, Vashu